Related Experiment Video
Updated: Aug 11, 2026

Determination of the Procoagulant Activity of Extracellular Vesicle (EV) Using EV-Activated Clotting Time (EV-ACT)
Published on: August 4, 2023
Disorders of coagulation in stroke
1Neurology, Emory University, Atlanta, GA 30322, USA.
Insights
Coagulopathies are linked to thrombosis, but their role in ischemic stroke requires further study. This review explores genetic advances and protein interactions in coagulation, highlighting their impact on cerebral venous thrombosis and ischemic stroke.
Area of Science:
- Neurology
- Hematology
- Genetics
Background:
- Coagulopathies are well-established contributors to thrombosis.
- The specific role of coagulopathies in ischemic stroke remains poorly understood.
- Understanding these roles is crucial for developing targeted therapies.
Purpose of the Study:
- To review recent advances in the genetics of coagulation.
- To examine the interactive roles of coagulation and anticoagulation proteins.
- To synthesize literature on protein dysregulation in cerebral venous thrombosis and ischemic stroke.
Main Methods:
- Literature review of recent advances in coagulation genetics.
- Analysis of interactive roles between coagulation and anticoagulation proteins.
- Synthesis of existing research on protein dysregulation in cerebrovascular events.
Main Results:
- Recent genetic discoveries have expanded our understanding of coagulation.
- Complex interactions between procoagulant and anticoagulant proteins are identified.
- Evidence supports protein dysregulation as a causative factor in specific thrombotic events.
Conclusions:
- Protein dysregulation in coagulation pathways is implicated in ischemic stroke.
- Further research into coagulation genetics and protein interactions is warranted.
- This understanding may lead to novel diagnostic and therapeutic strategies for stroke prevention.
Abstract:
The roles of the coagulopathies in thrombosis have been well established; however, the role in ischemic stroke is poorly understood. This article reviews the recent advances in the genetics of coagulation, the recently identified interactive roles of the coagulation and anticoagulation proteins, and the literature supporting protein dysregulation as a causative agent in cerebral venous thrombosis and ischemic stroke.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Stroke: Introduction and Types
Hemorrhagic Stroke l: Introduction

